| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2011 | CA2455145C Pregnancy-related serine protease |
| 01/18/2011 | CA2427347C Method and means for producing barley yellow dwarf virus resistant cereal plants |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2331263C A method of producing cells with a desired property by recursive sequence recombination |
| 01/18/2011 | CA2301204C Sugarcane bacilliform virus promoter |
| 01/18/2011 | CA2260858C Polynucleotide vaccine formulation against pathologies of the horse |
| 01/18/2011 | CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence |
| 01/18/2011 | CA2189055C Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 01/13/2011 | WO2011006133A2 Bioengineered silk protein-based nucleic acid delivery systems |
| 01/13/2011 | WO2011006072A2 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 01/13/2011 | WO2011005968A1 Codon-optimized factor vi i i variants and synthetic liver-specific promoter |
| 01/13/2011 | WO2011005849A1 Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene |
| 01/13/2011 | WO2011005587A1 Vaccine compositions and methods of use to protect against infectious disease |
| 01/13/2011 | WO2011005090A1 Method for increasing the resistance of a plant or a part thereof to a pathogen, method for screening the resistance of a plant or part thereof to a pathogen, and use thereof |
| 01/13/2011 | WO2011004843A1 Pharmaceutical composition for treatment of sirs or highly pathogenic influenza infection |
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2011004324A1 Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections |
| 01/13/2011 | WO2011004263A2 Conserved escherichia coli immunogens |
| 01/13/2011 | WO2011004148A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 01/13/2011 | WO2011004146A1 Chimaeric protein |
| 01/13/2011 | WO2011004129A1 Use of a co-product from a method for extracting lysozyme from egg whites, in order to obtain at least one basic egg white protein |
| 01/13/2011 | WO2011004054A1 Use of carbonic anhydrase ii for producing a drug |
| 01/13/2011 | WO2011004011A1 Variants of plasminogen and plasmin |
| 01/13/2011 | WO2011004005A1 Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors ahk2 and ahk3 |
| 01/13/2011 | WO2011003988A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | WO2011003968A1 A fungal protease and use thereof |
| 01/13/2011 | WO2011003936A1 Alphabodies for hiv entry inhibition |
| 01/13/2011 | WO2011003935A1 Parathyroid hormone related protein antagonists |
| 01/13/2011 | WO2011003896A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | WO2011003850A1 Method for providing fertile plants via induction of bbm during transformation |
| 01/13/2011 | WO2011003800A1 Plants having modulated carbon partitioning and a method for making the same |
| 01/13/2011 | WO2011003471A1 Method for providing mature transgenic recalcitrant plants via induction of bbm during regeneration |
| 01/13/2011 | WO2011003369A1 New tumor marker |
| 01/13/2011 | WO2010134686A3 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof |
| 01/13/2011 | WO2010128033A3 Method for purification of target polypeptides |
| 01/13/2011 | WO2010103070A3 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity |
| 01/13/2011 | WO2010099960A3 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 01/13/2011 | WO2010096693A3 Methods and materials for generating t cells |
| 01/13/2011 | WO2010095910A3 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof |
| 01/13/2011 | WO2010094722A3 Improved anti-serum albumin binding variants |
| 01/13/2011 | WO2010045586A3 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 01/13/2011 | US20110010805 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010799 Floral Transition Genes in Maize and Uses Thereof |
| 01/13/2011 | US20110010797 Method for changing nitrogen utilization efficiency in plants |
| 01/13/2011 | US20110010795 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/13/2011 | US20110010794 Method for improving plant tolerance to environmental stress |
| 01/13/2011 | US20110010789 Soybean variety a1016494 |
| 01/13/2011 | US20110010788 Soybean variety a1016174 |
| 01/13/2011 | US20110010787 Soybean variety a1016497 |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110010784 Insulin-like gene of prawns and uses thereof |
| 01/13/2011 | US20110010780 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 01/13/2011 | US20110009603 Method and composition for crystallizing G protein-coupled receptors |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009601 Labeled protein and method for obtaining the same |
| 01/13/2011 | US20110009599 Apo-2 receptor polypeptides |
| 01/13/2011 | US20110009598 Method of producing cell extract for cell-free protein synthesis |
| 01/13/2011 | US20110009597 RECOMBINANT GANODERMA LUCIDIUM IMMUNOMODULATORY PROTEIN (rLZ-8) AND USES THEREOF |
| 01/13/2011 | US20110009408 Methods for identifiying inhibitors against viruses that use a class i fusion protein |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110009336 Treatment of Cancers with Immunostimulatory HIV TAT Derivative Polypeptides |
| 01/13/2011 | US20110009329 Method for treating neurodegenerative diseases |
| 01/13/2011 | US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH) |
| 01/13/2011 | US20110009327 Bioactive nanocomposite material |
| 01/13/2011 | US20110009324 Stable Therapeutic Proteins |
| 01/13/2011 | US20110009323 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 01/13/2011 | US20110009320 Glucagon-like peptide-2 analogs |
| 01/13/2011 | US20110009319 Cripto antagonism of activin and tgf-b signaling |
| 01/13/2011 | US20110009317 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009315 Long-acting transient polymer conjugates of exendin |
| 01/13/2011 | US20110009314 Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof |
| 01/13/2011 | US20110009313 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009310 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 01/13/2011 | US20110009293 Nonseparation Assay Methods |
| 01/13/2011 | US20110009283 Identification of toxin ligands |
| 01/13/2011 | US20110008913 Tumor suppressor gene |
| 01/13/2011 | US20110008900 Depletion of plasma proteins |
| 01/13/2011 | US20110008891 Partial peptide of lacritin |
| 01/13/2011 | US20110008890 Self-Assembly of Peptide-Amphiphile Nanofibers Under Physiological Conditions |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter |
| 01/13/2011 | US20110008838 Chimeric varicella zoster virus virus-like particles |
| 01/13/2011 | US20110008830 Process for producing bio-gel and a bio-gel |
| 01/13/2011 | US20110008828 Methods of incorporating amino acid analogs into proteins |
| 01/13/2011 | US20110008812 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 01/13/2011 | US20110008795 Marker for detection of il-17-producing helper t-cell, and method for detection of il-17-producing helper t-cell |
| 01/13/2011 | US20110008792 Promoters for expression in modified vaccinia virus ankara |
| 01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008455 Crosslinked Protein Nanocrystals, Crosslinked Protein Nanoaggregates and Method of Preparation Thereof |
| 01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
| 01/13/2011 | US20110008380 Anaplasma Phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma |
| 01/13/2011 | US20110008379 Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| 01/13/2011 | US20110008378 Modified flagellin improved toll-like receptor 5 stimulating activity |